FDA.reportPublic FDA data

Dyanavel XR 2.5 MG per 1 ML 24 HR Extended Release Suspension

RxCUI
1720592
RxNorm name
Dyanavel XR 2.5 MG per 1 ML 24 HR Extended Release Suspension
Display name
Dyanavel XR 2.5 MG per 1 ML 24 HR Extended Release Suspension
Full name
Dyanavel XR 2.5 MG per 1 ML 24 HR Extended Release Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dyanavel XRAMPHETAMINENextWave Pharmaceuticals, Incae304b29-0b40-40ec-ad0d-76b742d4a9b92026-02-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1720592

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ae304b29-0b40-40ec-ad0d-76b742d4a9b9Dyanavel XR 2.5 MG per 1 ML 24 HR Extended Release SuspensionSY14These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 96020260224
ae304b29-0b40-40ec-ad0d-76b742d4a9b924 HR amphetamine 2.5 MG/ML Extended Release Suspension [Dyanavel]SBD14These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 96020260224
ae304b29-0b40-40ec-ad0d-76b742d4a9b9Dyanavel XR 2.5 MG in 1 mL 24HR Extended Release Oral SuspensionPSN14These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 96020260224
ae304b29-0b40-40ec-ad0d-76b742d4a9b924 HR Dyanavel 2.5 MG/ML Extended Release SuspensionSY14These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 96020260224